KemPharm Competitors and Similar CompaniesClear all
KemPharm's competitors and similar companies include F-star Biotechnology.
 KemPharm KemPharm is a biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases. |  F-star Biotechnology F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology. | |
Founding Date | Founding Date 2006 | Founding Date 2006 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Kissimmee, US HQ Blacksburg, US Coralville, US Coralville, US | Locations Cambridge, GB HQ Wien, AT Cambridge, US |
Employees | Employees 333% increase | Employees 39 |
Financial | ||
Revenue (est.) | Revenue (est.) $106.5m (FY, 2025) | Revenue (est.) £18.7m (FY, 2018) |
Net income | Net income $83.2m (FY, 2025) | Net income (£2.6m) (FY, 2018) |
For sources of this data, please see the company profile
View Company Profiles
F-star Biotechnology
HQ
Cambridge, GB
Employees
39
F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.
View company